Skip to main content
. 2019 Jan 14;2019(1):CD005431. doi: 10.1002/14651858.CD005431.pub4

Comparison 5. Tranexamic acid versus control.

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
1 Short‐term visual acuity from 20/20 to 20/40 3 303 Risk Ratio (M‐H, Fixed, 95% CI) 1.11 [0.98, 1.25]
2 Time to resolution of primary hemorrhage (days)     Other data No numeric data
3 Risk of secondary hemorrhage 5 578 Risk Ratio (M‐H, Fixed, 95% CI) 0.31 [0.17, 0.55]
4 Time to rebleed (days)     Other data No numeric data
5 Risk of corneal blood stain 2   Risk Ratio (M‐H, Fixed, 95% CI) Totals not selected
6 Risk of glaucoma or elevated IOP 4 543 Risk Ratio (M‐H, Fixed, 95% CI) 1.20 [0.73, 1.98]
7 Adverse effects: nausea or vomiting 2   Risk Ratio (M‐H, Fixed, 95% CI) Totals not selected
8 Duration of hospitalization (days)     Other data No numeric data